98%
921
2 minutes
20
Protein posttranslational modifications (PTMs) are often involved in the mediation or inhibition of protein-protein interactions (PPIs) within many cellular signaling pathways. Uncovering the molecular mechanism of PTM-induced multivalent PPIs is vital to understand the regulatory factors to promote inhibitor development. Herein, Rnd3 peptides with different PTM patterns as the binding epitopes and 14-3-3ζ protein were used as models to elucidate the influences of phosphorylation and farnesylation on binding thermodynamics and kinetics and their molecular mechanism. The quantitative thermodynamic results indicate that phosphorylated residues S210 and S218 (pS210 and pS218) and farnesylated C241 (fC241) enhance Rnd3-14-3-3ζ interactions in the presence of the essential pS240. However, distinct PTM patterns greatly affect the binding process. Initial association of pS240 with the phosphate-binding pocket of one monomer of the 14-3-3ζ dimer triggers the binding of pS210 or pS218 to another monomer, whereas the binding of fC241 to the hydrophobic groove on one 14-3-3ζ monomer induces the subsequent binding of pS240 to the adjacent pocket on the same monomer. Based on the experimental and molecular simulation results, we estimate that pS210/pS218 and pS240 mediate the multivalent interaction through an additive mechanism, whereas fC241 and pS240 follow an induced fit mechanism, in which the cooperativity of these two adjacent PTMs is reflected by the index described in our established thermodynamic binding model. Besides, these proposed binding models have been further used for describing the interaction between 14-3-3ζ and other substrates containing adjacent phosphorylation and lipidation groups, indicating their potential in general applications. These mechanistic insights are significant for understanding the regulatory factors and the design of PPI modulators.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179448 | PMC |
http://dx.doi.org/10.1039/d0sc05838f | DOI Listing |
Int J Biol Macromol
September 2025
Guangxi Key Laboratory of Electrochemical and Magneto-chemical Functional Materials, College of Chemistry and Bioengineering, Guilin University of Technology, 541006 Guilin, China. Electronic address:
The process of aging is understood to be associated with the presence of oxidative damage to cells. The development of synthetic prenylated proteins for therapeutic purposes has been a subject of research and development for several decades. The present review encompasses information regarding natural and synthetic prenylated proteins and macropeptides, in addition to the anti-aging effects of these isoprenoids and their underlying mechanisms.
View Article and Find Full Text PDFCell Death Dis
July 2025
Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Hutchinson-Gilford progeria syndrome (HGPS) is caused by progerin, an internally truncated prelamin A that does not undergo the ZMPSTE24 processing step that releases prelamin A's farnesylated carboxyl terminus; consequently, progerin remains farnesylated. Progerin and full-length farnesyl-prelamin A are equivalent in their abilities to disrupt the nuclear lamina and trigger nuclear membrane ruptures and cell death, but they differ markedly in their abilities to cause arterial pathology. In HGPS mice (Lmna), progerin causes loss of aortic smooth muscle cells (SMCs) by 12 weeks, whereas farnesyl-prelamin A in Zmpste24 mice does not trigger SMC loss-even at 21 weeks.
View Article and Find Full Text PDFJ Adv Res
June 2025
College of Exercise and Health, Shenyang Sport University, Shenyang 110102, China; School of Exercise and Health and Collaborative Innovation Center for Sports and Public Health, Shanghai University of Sport, Shanghai 200438, China. Electronic address:
Background: Bone metabolic diseases constitute a group of disorders characterized by abnormal alterations in bone mass and skeletal metabolism, often resulting from oxidative stress, nutritional deficiencies, and various other etiological factors. Post-translational modification (PTM), a critical mechanism of protein regulation, plays a pivotal role in the pathogenesis of bone metabolic diseases. While previous reviews have primarily focused on the individual regulatory functions of common PTMs, such as phosphorylation, methylation, and ubiquitination, they have largely overlooked the dynamic interactions and cross talk among different PTMs.
View Article and Find Full Text PDFMethods Mol Biol
May 2025
Department of Oncology and Metabolism, University of Sheffield, Medical School, Sheffield, UK.
This chapter describes the analysis of signaling pathways in bone cells by the use of Western blotting and immunoprecipitation, including a step-by-step guide to cell culture techniques, cellular and subcellular fractionation, protein isolation, purification, measurement, electrophoretic transfer, and detection.
View Article and Find Full Text PDFInt Immunopharmacol
June 2025
Department of Rheumatology and Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address:
Background: Isorhapontigenin (ISO) has been reported to exhibit various therapeutic effects including anti-inflammation and anti-cancer. However, it is still unclear whether ISO has therapeutic efficacy on rheumatoid arthritis (RA). This study aimed to determine the effects of ISO on regulating functions of RA fibroblast-like synoviocytes (FLS) and further to explore the underlying mechanisms.
View Article and Find Full Text PDF